SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Myriad Genetics, Inc. - MYGN
NEW YORK, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ: MYGN). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw. …